SCHEMBL1978480

SCHEMBL1978480

CC1(Cc2cccnc2)CC(=O)c2cc(Br)ccc2O1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 2/20 0.47
GLA P06280 2/20 0.47
GAA P10253 2/20 0.47
HPGD P15428 2/20 0.47
CASP1 P29466 2/20 0.47
HSD17B10 Q99714 2/20 0.47
CASP7 P55210 1/20 0.47
AKT1 P31749 1/20 0.41
MAPT P10636 2/20 0.39
MAOB P27338 2/20 0.39
TBXAS1 P24557 1/20 0.37
PBRM1 Q86U86 1/20 0.36
GABRA1 P14867 1/20 0.35
GABRA5 P31644 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
RIPK1 Q13546 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1978518 0.79 AKT1 (0.44) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL1978508 0.79 MAOB (0.44) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL10237816 0.74 AKT1 (0.54) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL1978029 0.74 CYP3A4 (0.37) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL8514081 0.73 AKT1 (0.56) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL1983002 0.72 BACE1 (0.40) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL874004 0.72 AKT1 (0.60) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL1821389 0.71 MAPT (0.71) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL1981849 0.70 AKT1 (0.42) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL6837032 0.70 SIGMAR1 (0.51) KDM4EALDH1A1HPGDAKT1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011072064-A1 S PIRO [CHROMAN - 4, 4 ' - IMIDAZOL] ONES AS BETA - SECRETASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2011-06-16 WO disclosed